Literature DB >> 31174709

What happens to agreement over time? A longitudinal study of self-reported substance use compared to saliva toxicological testing among subsidized housing residents.

Alexis Rendon1, Eun-Young Mun1, Emily Spence-Almaguer1, Scott T Walters2.   

Abstract

The agreement between self-reported and toxicologically verified substance use provides important information about the validity of self-reported use. While some studies report aggregate agreement across follow-up points, only a few have examined the agreement at each time point separately. An overall rate of agreement across time may miss changes that occur as people progress through a research study. In this study, a sample of 644 adults (43.8% male, 32.6% White, 57.0% Black, 90.2% ages 36+) residing in subsidized housing was used to determine the agreement between self-reported use and saliva toxicological testing for marijuana, cocaine, PCP, amphetamine, and methamphetamine at three different time points. Agreement between saliva toxicological testing and self-report ranged between 84.2% and 94.3% for different substances over time. Higher rates of agreement were found for cocaine than had been reported by previous studies. Statistically significant differences in the odds ratios of concordance over time (baseline, 6-month, and 12-month follow-up) were found for marijuana and the combined category for PCP, amphetamine, and methamphetamine. Our findings suggest that oral fluid drug tests generally withstand community field assessments and result in relatively high levels of agreement for marijuana, cocaine, PCP, amphetamine, and methamphetamine use, when compared to self-report. Because of the ease of sample collection and low chance of adulteration, we conclude that saliva testing is a viable method for toxicological confirmation of substance use behavior in this setting.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Agreement; Oral fluid drug test; Self-report; Subsidized housing; Substance use; Timeline follow-back

Mesh:

Year:  2019        PMID: 31174709      PMCID: PMC6721608          DOI: 10.1016/j.jsat.2019.03.002

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  31 in total

1.  Comparisons of self-report data and oral fluid testing in detecting drug use amongst new treatment clients.

Authors:  Joanne Neale; Michele Robertson
Journal:  Drug Alcohol Depend       Date:  2003-07-20       Impact factor: 4.492

2.  Preliminary outcomes from the assertive continuing care experiment for adolescents discharged from residential treatment.

Authors:  Mark D Godley; Susan H Godley; Michael L Dennis; Rodney Funk; Lora L Passetti
Journal:  J Subst Abuse Treat       Date:  2002-07

3.  Brief treatments for cannabis dependence: findings from a randomized multisite trial.

Authors: 
Journal:  J Consult Clin Psychol       Date:  2004-06

4.  An overview of the use of urine, hair, sweat and saliva to detect drug use.

Authors:  Kate Dolan; David Rouen; Jo Kimber
Journal:  Drug Alcohol Rev       Date:  2004-06

5.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

6.  Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.

Authors:  Ahmed Elkashef; Tyson H Holmes; Daniel A Bloch; Steve Shoptaw; Kyle Kampman; Malcolm S Reid; Eugene Somoza; Domenic Ciraulo; John Rotrosen; Deborah Leiderman; Ann Montgomery; Frank Vocci
Journal:  Addiction       Date:  2005-03       Impact factor: 6.526

7.  Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study.

Authors:  Kathleen M Carroll; Samuel A Ball; Charla Nich; Steve Martino; Tami L Frankforter; Christiane Farentinos; Lynn E Kunkel; Susan K Mikulich-Gilbertson; Jon Morgenstern; Jeanne L Obert; Doug Polcin; Ned Snead; George E Woody
Journal:  Drug Alcohol Depend       Date:  2005-09-28       Impact factor: 4.492

8.  Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.

Authors:  David McDowell; Edward V Nunes; Angela M Seracini; Jami Rothenberg; Suzanne K Vosburg; Guoguang J Ma; Eva Petkova
Journal:  Drug Alcohol Depend       Date:  2005-11-01       Impact factor: 4.492

9.  Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial.

Authors:  Kathleen M Carroll; Lisa R Fenton; Samuel A Ball; Charla Nich; Tami L Frankforter; Julia Shi; Bruce J Rounsaville
Journal:  Arch Gen Psychiatry       Date:  2004-03

10.  Is oral fluid analysis as accurate as urinalysis in detecting drug use in a treatment setting?

Authors:  Gerald A Bennett; Eleanor Davies; Peter Thomas
Journal:  Drug Alcohol Depend       Date:  2003-12-11       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.